Results support advancing LB-102 to Phase 3 clinical development in schizophrenia NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc., a clinical-stage biopharmaceutical company ...
Today, I am privileged to be living beyond my diagnosis, as are millions of people from around the world with schizophrenia. When we think of the word “schizophrenia,” many negative thoughts ...
Some results have been hidden because they may be inaccessible to you